# OnCo record nct04306224 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04306224/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04306224", "NCT04306224" ;
  schema:name "A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas"@en ;
  schema:description "A phase 1 trial of IMC-002 run by ImmuneOncia Therapeutics Inc., completed."@en ;
  schema:url <https://onco.cc/trials/nct04306224/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04306224> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/imc-002/> ;
  onco:companies <https://onco.cc/companies/immuneoncia-therapeutics/> .